# Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection

> **NCT05332444** · PHASE4 · RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 450 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** susceptibility-guided tailored therapy (Group A)
- **DRUG:** guidelines-recommended empiric therapy (Group B)

## Key facts

- **NCT ID:** NCT05332444
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-11
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05332444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05332444, "Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05332444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*